Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma
AffiliationNational Health and Medical Research Council Centre of Excellence in Severe Asthma , Newcastle , Australia
MetadataShow full item record
AbstractBackground: People with severe asthma experience frequent life-threatening acute asthma events. A Lancet commission recently highlighted that terms "exacerbations" and "flare-ups" are seen to trivialize these episodes and recommended use of the term "attacks." Clinicians however, preferentially use the term "exacerbation" and some guidelines recommend the use of "exacerbation" with patients. Objective: This descriptive qualitative study aimed to understand the patient's experience and perspectives of these events and language used to describe them. Methods: Semi-structured one-on-one interviews were conducted in Australia and the UK in 18 people with severe asthma and 10 with mild-moderate asthma regarding their usage and preferences for such terminologies. Additionally, nine people with severe asthma participated in two focus groups in which use of preferred terminology was explored. Results: Mean age of participants was 57?±?14.03?yr and 65% were female. A total 67 quotes were recorded in which 16 participants with severe asthma spontaneously used either the term "attack," "flare-up" and/or "exacerbation." Of these quotes, all 16 participants used "attack," one used all three terms and two used both "exacerbation" and "attack." The term "attack" was used to describe frightening events having major impacts on participant's lives, whereas "exacerbation" and "flare-up" were used to refer to both severe and mild, transient asthma-related events. Conclusion: Usage of the term "attack" was preferred by patients with severe asthma. Adoption of this language may assist in patient-clinician communication and disease management and outcomes. Wider stakeholder engagement is needed to confirm this suggestion. Abbreviations FEV1 forced expiratory volume in 1?second ATS American Thoracic Society ERS European Respiratory Society ACQ Asthma Control Questionnaire ICS inhaled corticosteroids OCS oral corticosteroids BTS British Thoracic Society SIGN Scottish Intercollegiate Guidelines Network WAP written action plan.
CitationJones KA, Gibson PG, Yorke J, Niven R, Smith A, McDonald VM. Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. J Asthma. 2019 Sep 16:1-10.
JournalJournal of Asthma
- Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
- Authors: Chauhan BF, Jeyaraman MM, Singh Mann A, Lys J, Abou-Setta AM, Zarychanski R, Ducharme FM
- Issue date: 2017 Mar 16
- Patient and physician asthma deterioration terminology: results from the 2009 Asthma Insight and Management survey.
- Authors: Blaiss MS, Nathan RA, Stoloff SW, Meltzer EO, Murphy KR, Doherty DE
- Issue date: 2012 Jan-Feb
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.
- Authors: Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E
- Issue date: 2015 Sep
- Anti-IL5 therapies for asthma.
- Authors: Farne HA, Wilson A, Powell C, Bax L, Milan SJ
- Issue date: 2017 Sep 21
- Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
- Authors: Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E, BELT Investigators.
- Issue date: 2015 Oct 27